Frequency Therapeutics

Frequency Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 47
Employees
  • Stock Symbol
  • FREQ
Stock Symbol
  • Share Price
  • $22.98
  • (As of Friday Closing)

Frequency Therapeutics General Information

Description

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 19 Presidential Way
  • Woburn, MA 01801
  • United States
+1 (866) 000-0000

Frequency Therapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Frequency Therapeutics Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$22.98 $22.96 $11.17 - $28.78 $712M 31M 255K -$0.82

Frequency Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 333,800 526,014
Revenue 36,211 28,947 0 0
EBITDA (19,329) (19,717) (18,408) (19,532)
Net Income (17,833) (18,746) (19,168) (20,237)
Total Assets 215,721 223,218 44,548 19,787
Total Debt 2,441 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Frequency Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Frequency Therapeutics‘s full profile, request access.

Request a free trial

Frequency Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Frequency Therapeutics‘s full profile, request access.

Request a free trial

Frequency Therapeutics Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
MabVax Therapeutics Formerly VC-backed San Diego, CA 0 000.00 000000&0 000.00
0000000 0000000000 Venture Capital-Backed Boston, MA 00000 0000000000 0 00000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
000 000000 Corporation San Diego, CA 00 00000 000000 - 000 00000
00000000 000000000 Venture Capital-Backed London, United Kingdom 00 000.00 000000000000 000.00

Frequency Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
David Lucchino Chief Executive Officer & Founder
Christopher Loose Ph.D Chief Scientific Officer
Carl LeBel Ph.D Executive
Wendy Arnold Executive
William Chin MD Executive Vice President of Clinical and Translational Science

2 Former Executives

Frequency Therapeutics Board Members (9)

To view Frequency Therapeutics‘s full board member team, request access »
Name Representing Role Since
Daguang Wang Ph.D Yongjin Group Board Observer 000 0000
Frederick Shane DNU_Axil Capital Partners Board Observer 000 0000
Joel Marcus JD Self Board Member 000 0000
Marc Cohen Self Chairman & Board Member 000 0000
Marc Kozin Self Board Member 000 0000

1 Former Board Member

Frequency Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Frequency Therapeutics‘s full profile, request access.

Request a free trial